Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.

For both cohorts, there was a broad range of OBT susceptibility scores at baseline and a clear trend toward reduced incidence of PDVF among participants with higher overall susceptibility score to newly used antiretrovirals (OSS-new) ( Table 1 ).

also in 19,460 other papers